- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2025 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Featured Content
European Biotech Targeting Anti-ageing
Oct 2nd 2024
Novel mitophagy inducers and gene therapies that restore cellular function and decelerate the ageing process.
Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?
Mar 4th 2024
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Training for Operational Excellence
Dec 3rd 2023
The bio/pharmaceutical industry is struggling with the challenge of staffing and training.
Billions of Reasons to be Buoyant
Sep 2nd 2023
Pharma's ability to continually reinvent itself will be critical in growing future business operations.
Latest Videos
Latest News
Capstone Health Alliance and Bright Path Laboratories Enter Drug Shortage Agreement
August 24th 2023
Bright Path will develop and produce APIs for hospitals facing drug shortages in the Capstone Health Alliance.
Revive Therapeutics Announces Initiation of New Bucillamine Formulation Development
August 24th 2023
The formulation will be used to mitigate emerging infectious diseases and public health emergencies.
LEO Pharma to Acquire Timber Pharmaceuticals
August 22nd 2023
The deal is worth up to $36 million with an initial upfront consideration of $14 million, with an additional $22 million in contingent value rights (CVRs) that is payable upon achieving certain milestones.
Absci and Caltech Collaborate to Accelerate Affordable HIV Therapeutic Vaccine
August 17th 2023
A major grant from the Bill & Melinda Gates Foundation will bolster efforts to fight the global HIV/AIDS epidemic.
Parexel and Partex Enter AI Alliance
August 16th 2023
The collaboration between Parexel and Partex is designed to leverage artificial intelligence-powered solutions to accelerate drug discovery and development.
Gilead and Tentarix Strike Three Cancer And Inflammation Partnership Deals
August 16th 2023
Gilead and Tentarix established three multi-year collaborations to discover and develop multi-functional, conditional protein therapeutics for oncology and inflammatory diseases.
Harmony Biosciences to Acquire Zynerba Pharmaceuticals
August 15th 2023
Zygel is the first and only pharmaceutically manufactured, synthetic cannabidiol that is formulated as a patient-protected permeation-enhanced gel for transdermal delivery.
Lilly Completes Spate of Acquisitions
August 15th 2023
The completion of three acquisitions of Versanis Bio, Sigilon Therapeutics, and DICE Therapeutics boosts Eli Lilly and Company’s product pipeline in obesity, diabetes, and immunology.
Rakuten Medical Signs Exclusive Licensing Agreement with Hikma for Cancer Treatments in MENA
August 15th 2023
Under the exclusive agreement, Hikma will commercialize products in Rakuten Medical’s pipeline for cancer treatment in the Middle East and North Africa region.
United Kingdom Biotech Report Finds 29% Uptick in Funding
August 14th 2023
A report from the UK Bioindustry Association report indicated that biotech venture and public financing rose from £295 million in the first quarter to £382 million in the second quarter.